Icecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary

Icecure Medical

13/08/2025 14:32

Icecure Medical Ltd ICCM.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended June 30, identical to the same quarter last year.  The mean expectation of two analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -7 cents to -6 cents per share.

Revenue fell 48.1% to $525.00 thousand from a year ago; analysts expected $662.50 thousand.

Icecure Medical Ltd's reported EPS for the quarter was a loss of 12 cents​.

The company reported a quarterly loss of $3.36 million.

Icecure Medical Ltd shares had fallen by 17.6% this quarter and lost 25.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Icecure Medical Ltd is $3.00, about 72.7% above its last closing price of $0.82

This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.06
-0.06
Met
Mar. 31 2025
-0.08
-0.06
Beat
Dec. 31 2024
-0.07
-0.08
Missed
Sep. 30 2024
-0.07
-0.08
Missed